Heart Failure Remote Monitoring

Learn more about our AI-based solution to effectively predict and treat heart failure.
Request a demo

Advanced technologies in heart failure management are designed to predict potential adverse events, enhancing patients’ life expectancy, and reducing the financial burden associated with hospital readmissions.


Implicity is a unique platform that aggregates and processes data from cardiac implantable electronic devices (CIEDs) and weight scales. This integration particularly benefits many heart failure patients who rely on CIEDs. By centralizing all relevant data on one platform, Implicity streamlines the management of a patient’s clinical situation, enhancing efficiency and clarity for healthcare providers. This consolidation allows patients to receive personalized support tailored to their specific needs, directly contributing to an improved quality of life from the comfort and safety of their homes.


Through the Implicity Heart Failure platform, physicians are equipped with a dynamic solution, enabling proactive management of patient health progression. This approach not only facilitates the avoidance of hospital admissions but also addresses the need to control healthcare expenses efficiently.

*Not currently available in the United States

Product and Services to improve clinical outcome

An alert is automatically triggered when the algorithm detects a significant weight increase or a lack of weighing activity. (CE marked algorithm*)

Withings is not owned by Implicity.
One global platform – Aggregates and processes data from cardiac implantable devices (CIEDs) and weight scales

The platform integrates with the highly reliable Withings scale, ensuring seamless data connectivity.

CE-marked algorithms are designed to identify significant weight fluctuations or instances of data absence due to the scale not being used.
Routine self-assessment of symptoms through SMS.
Dedicated alert management services operated by a team of nurses.
Implicity platform makes it possible to monitor patients with cardiac devices and patients with heart failure on a single interface. Having all their data and information in a single platform saves time and enables early diagnosis of cardiac decompensations.

Weight alerts triage is performed by a nurse offered by Implicity. This service allows early access to alerts through facilitated discussions with the Implicity nurse and helps achieve a significant gain of time.

Dr. Jérôme Thévenin

Hôpital Privé de la Loire, Saint-Étienne

*IM009: 2021. Manufacturer: Implicity. IM009 is a software as a medical device (SaMD) intended to be used as an adjunct of a remote monitoring platform to follow-up target population patients. IM009 is compatible with devices with remote monitoring feature such as cardiac implantable electronic devices and connected weight scales. The three main intents of IM009 are to label observations generated by medical devices according to predefined categories, create clinically relevant observations for worsening atrial fibrillation and/or rapid weight gain in the context of heart failure, based on data recorded by the device and label Atrial Fibrillation burden observations generated by cardiac implantable electronic device (CIED) as to be hidden or relevant for health care provider based on patient’s anticoagulation status. Hence, IM009 is designed to reduce the workload burden of healthcare providers/professionals in charge of reviewing the observations received from the patients’ devices. IM009 is not intended for use in life supporting or sustaining systems or Alarm devices and as a solely means of diagnosis. It is offered to healthcare providers/professionals on an advisory basis only in conjunction with the physician’s knowledge of ECG patterns, patient background, clinical history, symptoms, and other diagnostic information. Class I, according to Medical Device Directive 93/42/EEC. See the instructions for use for more information.